The COVID-19 epidemic posed new and pressing challenges for pharmaceutical researchers. Gilead Sciences’ Veklury was the first drug to treat COVID-19 infection that was provisionally approved in more than 50 countries. It is also the first product to receive a full, and therefore not temporary, and emergency license from the U.S. Food and Drug Administration (FDA) in October 2020…


Hungarian InnoStudio Zrt., Which is the leading international player in space chemistry as a new industry and CycloLab Kft., The primary European manufacturer of the excipient of remdesivir, is the first in the world to investigate the possible effects of microgravity during the remdesivir-SBECD interaction.

Read the full Hungarian article on